Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...
By KENYA HUNTER The majority of strokes could be prevented, according to new guidelines aimed at helping people and their ...
The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these ...
Twelve Scots were rushed to A&E with complications from 'miracle' weight-loss injections in the same health board area where ...